Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
M.D. Anderson Cancer Center
Hoffmann-La Roche
Duke University
AstraZeneca
Poseida Therapeutics, Inc.
University of Washington
OHSU Knight Cancer Institute
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
TCR2 Therapeutics
Jonsson Comprehensive Cancer Center
Cancer Research UK
National Cancer Institute (NCI)
Tempus AI
University Hospital, Antwerp
Cybrexa Therapeutics
Carisma Therapeutics Inc
Revolution Medicines, Inc.
NGM Biopharmaceuticals, Inc
ENB Therapeutics, Inc
University Hospital, Geneva
NGM Biopharmaceuticals, Inc